Penumbra has announced the CE mark and European launch of BMX81 and BMX96—devices designed for the neurovascular management of ischaemic and haemorrhagic stroke. A company press release also notes that these technologies constitute Penumbra’s most advanced neuro access offerings.
This announcement further expands the company’s neuro portfolio in Europe following the launch of three new RED reperfusion catheters—RED 43, RED 72 with SENDit technology, and RED 78—back in May.
“I need to be able to trust that my access catheters can provide the stability that I need. The new BMX catheters promise excellent support. With their expanded inner diameters, I will be able to increase therapeutic options for my patients, especially when going radial,” said Markus Holtmannspötter (Klinikum Nürnberg, Nürnberg, Germany).
Unlike traditional access catheters, Penumbra’s BMX81 and BMX96 are made using laser-cut stainless steel hypotube technology, offering stability and trackability, the company’s recent release notes, adding that they are designed to allow physicians to easily navigate the brain’s complex anatomy via either a femoral or radial access approach. The stainless steel hypotube also allows for a larger inner diameter while maintaining a lower outer diameter without compromising support, expanding intraprocedural options in both ischaemic and haemorrhagic stroke.
“Physicians in Europe now have more options to serve their patients using our expanded portfolio. With five innovative devices introduced in Europe in a matter of months, our dedication to improving stroke care enables us to provide physicians with customised stroke solutions,” said Joan Kristensen, head of the Europe, Middle East and Africa region for Penumbra. “In all modesty, Penumbra provides physicians with the widest aspiration thrombectomy stroke portfolio on the market.”
With 20 years of experience optimising science-based aspiration thrombectomy (S-BAT), Penumbra says its catheters are engineered with the latest technology in trackability and aspiration to address a wide range of large vessel occlusions, and to navigate the challenging vasculature of the brain.
